Pragmabio
Pragmabio is a biotech company in South San Francisco, United States, founded in 2019. It has raised $10.0M across 1 round, most recently a $10.0M Series A in March 2023.
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2019
- Website
- pragmabio.com
- Total Funding
- $10.0M
- Last Round
- $10.0M Series AMar 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Pragmabio seeks cures for undruggable immunological disorders. It uses real-world data and synthetic biology to map biological signatures associated with clinical outcomes across multiple layers, with the aim of producing natural chemistry that has therapeutic potential for treating these disorders.
Summary
It lists 11–50 employees. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Mar 2023. Investors include The Venture Collective, Merck Global Health Innovation Fund and Viking Global.
Funding History
Mar 2023
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pragmabio"><img src="https://indexed.vc/api/badge/company/pragmabio" alt="Pragmabio on Indexed.vc" width="260" height="76" /></a>